期刊
ONCOGENE
卷 31, 期 49, 页码 5073-5080出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/onc.2011.657
关键词
S6K1; mTOR; estrogen; rapamycin; breast cancer
资金
- NIH [CA151112]
- Atol Charitable Trust
- Wendy Will Case Cancer Fund
- Yeshiva University
- S Daniel Abraham Honors Program of Yeshiva University
The 40S ribosomal S6 kinase 1 (S6K1) is an important regulator of cell growth. Expression of S6K1 is often elevated in breast cancer cells. However, the transcriptional mechanism of S6K1 overexpression is not understood. In this report, we demonstrate that estrogen activates expression of S6K1 via estrogen receptor (ER) a in ER-positive breast cancer cells. We also show that estrogen acts on the proximal promoter of the S6K1 gene in a mechanism involving the transcriptional factor GATA-3. Finally, we provide data that support the importance of estrogenic regulation of S6K1 expression in breast cancer cell proliferation. S6K1 directly phosphorylates and regulates ligand-independent activity of ER alpha, while ERa upregulates S6K1 expression. This S6K1-ER alpha relationship creates a positive feed-forward loop in control of breast cancer cell proliferation. Furthermore, the co-dependent association between S6K1 and ER alpha may be exploited in the development of targeted breast cancer therapies. Oncogene (2012) 31, 5073-5080; doi:10.1038/onc.2011.657; published online 30 January 2012
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据